MT3 and early-onset autosomal dominant Alzheimer disease: Metallothioneins (MTs) are cysteine-rich metal-binding proteins that chelate metals and inhibit oxidative stress, inflammation, and mitochondrial dysfunction induced by metals, while MT-III is reduced in Alzheimer’s disease [69].